159 related articles for article (PubMed ID: 278843)
1. Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues.
Glennon RA; Liebowitz SM; Mack EC
J Med Chem; 1978 Aug; 21(8):822-5. PubMed ID: 278843
[TBL] [Abstract][Full Text] [Related]
2. Serotonin receptor affinities of psychoactive phenalkylamine analogues.
Glennon RA; Liebowitz SM; Anderson GM
J Med Chem; 1980 Mar; 23(3):294-9. PubMed ID: 7365744
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives.
Kline TB; Benington F; Morin RD; Beaton JM; Glennon RA; Domelsmith LN; Houk KN; Rozeboom MD
J Med Chem; 1982 Nov; 25(11):1381-3. PubMed ID: 6815326
[TBL] [Abstract][Full Text] [Related]
4. Serotonin receptor binding affinities of tryptamine analogues.
Glennon RA; Gessner PK
J Med Chem; 1979 Apr; 22(4):428-32. PubMed ID: 430481
[TBL] [Abstract][Full Text] [Related]
5. Demethyl analogues of psychoactive methoxyphenalkylamines: synthesis and serotonin receptor affinities.
Glennon RA; Liebowitz SM; Leming-Doot D; Rosecrans JA
J Med Chem; 1980 Sep; 23(9):990-4. PubMed ID: 7411554
[TBL] [Abstract][Full Text] [Related]
6. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE
J Med Chem; 2000 Nov; 43(24):4701-10. PubMed ID: 11101361
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a novel series of N,N-dimethylisotryptamines.
Glennon RA; Jacyno JM; Young R; McKenney JD; Nelson D
J Med Chem; 1984 Jan; 27(1):41-5. PubMed ID: 6581313
[TBL] [Abstract][Full Text] [Related]
8. Studies on several 7-substituted N,N-dimethyltryptamines.
Glennon RA; Schubert E; Jacyno JM; Rosecrans JA
J Med Chem; 1980 Nov; 23(11):1222-6. PubMed ID: 6779006
[TBL] [Abstract][Full Text] [Related]
9. Benzofuran bioisosteres of hallucinogenic tryptamines.
Tomaszewski Z; Johnson MP; Huang X; Nichols DE
J Med Chem; 1992 May; 35(11):2061-4. PubMed ID: 1534585
[TBL] [Abstract][Full Text] [Related]
10. Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis.
Sadzot B; Baraban JM; Glennon RA; Lyon RA; Leonhardt S; Jan CR; Titeler M
Psychopharmacology (Berl); 1989; 98(4):495-9. PubMed ID: 2505289
[TBL] [Abstract][Full Text] [Related]
11. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793
[TBL] [Abstract][Full Text] [Related]
12. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
Cozzi NV; Gopalakrishnan A; Anderson LL; Feih JT; Shulgin AT; Daley PF; Ruoho AE
J Neural Transm (Vienna); 2009 Dec; 116(12):1591-9. PubMed ID: 19756361
[TBL] [Abstract][Full Text] [Related]
13. Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.
Lyon RA; Titeler M; Seggel MR; Glennon RA
Eur J Pharmacol; 1988 Jan; 145(3):291-7. PubMed ID: 3350047
[TBL] [Abstract][Full Text] [Related]
14. [Studies on hallucinogens. II. Synthesis of N,N-dimethyltryptamine (DMT) and its related compounds (author's transl)].
Ono M; Shimamine M; Takahashi K
Eisei Shikenjo Hokoku; 1973; 91(0):36-8. PubMed ID: 4527540
[No Abstract] [Full Text] [Related]
15. Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.
Pierce PA; Peroutka SJ
Psychopharmacology (Berl); 1989; 97(1):118-22. PubMed ID: 2540505
[TBL] [Abstract][Full Text] [Related]
16. Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities.
Glennon RA; Young R; Rosecrans JA; Kallman MJ
Psychopharmacology (Berl); 1980; 68(2):155-8. PubMed ID: 6776558
[TBL] [Abstract][Full Text] [Related]
17. Effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats.
Walters JK; Sheard MH; Davis M
Pharmacol Biochem Behav; 1978 Jul; 9(1):87-90. PubMed ID: 279938
[TBL] [Abstract][Full Text] [Related]
18. Unreliability of the rat stomach fundus as a predictor of hallucinogenic activity in substituted phenethylamines.
Nichols DE; Schooler D; Yeung MC; Oberlender RA; Zabik JE
Life Sci; 1984 Sep; 35(13):1343-8. PubMed ID: 6482656
[TBL] [Abstract][Full Text] [Related]
19. The electronic and serotonin receptor binding affinity properties of N,N-dimethyltryptamine analogs.
Glennon RA; Gessner PK
Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):453-65. PubMed ID: 270770
[TBL] [Abstract][Full Text] [Related]
20. Identification of Psychoplastogenic
Dunlap LE; Azinfar A; Ly C; Cameron LP; Viswanathan J; Tombari RJ; Myers-Turnbull D; Taylor JC; Grodzki AC; Lein PJ; Kokel D; Olson DE
J Med Chem; 2020 Feb; 63(3):1142-1155. PubMed ID: 31977208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
